Exactech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Exactech and buy or sell other stocks, ETFs, and their options commission-free!

About EXAC

Exactech, Inc. engages in the development, manufacture, distribution, and sale of orthopedic implant devices. It offers bone and joint restoration products for hips, knees, and extremities; and other advanced surgical technologies. 

CEO
Aurelio Sahagun, MBA
CEOAurelio Sahagun, MBA
Employees
Employees
Headquarters
Gainesville, Florida
HeadquartersGainesville, Florida
Founded
1985
Founded1985
Employees
Employees

EXAC Key Statistics

Market cap
707.50M
Market cap707.50M
Price-Earnings ratio
2.46K
Price-Earnings ratio2.46K
Dividend yield
Dividend yield
Average volume
339.09K
Average volume339.09K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$50.95
52 Week high$50.95
52 Week low
$23.75
52 Week low$23.75

Stock Snapshot

The current Exactech(EXAC) stock price is $49.30, with a market capitalization of 707.5M. The stock trades at a price-to-earnings (P/E) ratio of 2462.50.

On 2026-04-07, Exactech(EXAC) stock opened at —, reached a high of —, and a low of —.

Exactech(EXAC) shares are trading with a volume of 0, against a daily average of 339.09K.

During the past year, Exactech(EXAC) stock moved between $23.75 at its lowest and $50.95 at its peak.

During the past year, Exactech(EXAC) stock moved between $23.75 at its lowest and $50.95 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.